On November 17, 2023, Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) opened at $4.60, lower -12.35% from the last session. During the day, the shares moved up to $4.65 and dropped to $3.895 before settling in for the closing price of $4.57. Price fluctuations for RVPH have ranged from $3.03 to $9.25 over the past 52 weeks.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Company’s average yearly earnings per share was noted -17.60% at the time writing. With a float of $17.69 million, this company’s outstanding shares have now reached $20.45 million.
Let’s determine the extent of company efficiency that accounts for 10 employees.
Reviva Pharmaceuticals Holdings Inc. (RVPH) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Reviva Pharmaceuticals Holdings Inc. is 21.89%, while institutional ownership is 11.84%.
Reviva Pharmaceuticals Holdings Inc. (RVPH) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.44 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.37) by -$0.07. This company achieved a return on equity of -118.72. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.60% per share during the next fiscal year.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Trading Performance Indicators
Check out the current performance indicators for Reviva Pharmaceuticals Holdings Inc. (RVPH). In the past quarter, the stock posted a quick ratio of 0.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.69, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.11 in one year’s time.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc. (RVPH)
Looking closely at Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH), its last 5-days average volume was 0.94 million, which is a jump from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 8.71%. Additionally, its Average True Range was 0.72.
During the past 100 days, Reviva Pharmaceuticals Holdings Inc.’s (RVPH) raw stochastic average was set at 14.68%, which indicates a significant increase from 4.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.96% in the past 14 days, which was higher than the 118.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.87, while its 200-day Moving Average is $5.15. However, in the short run, Reviva Pharmaceuticals Holdings Inc.’s stock first resistance to watch stands at $4.48. Second resistance stands at $4.94. The third major resistance level sits at $5.23. If the price goes on to break the first support level at $3.72, it is likely to go to the next support level at $3.43. Now, if the price goes above the second support level, the third support stands at $2.96.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Key Stats
There are currently 22,650K shares outstanding in the company with a market cap of 90.83 million. Presently, the company’s annual sales total 0 K according to its annual income of -24,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,440 K.